Study of the Cardioprotective Properties of Uridine-5'-Monophosphate and Uridine in a Rat Model of Myocardial Damage Induced by Isoprenaline
- Authors: Belosludtseva N.V1, Uryupina T.A1, Khurtin D.A2, Khunderyakova N.V1, Mironova G.D1
-
Affiliations:
- Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences
- Mari State University
- Issue: Vol 69, No 4 (2024)
- Pages: 846-855
- Section: Complex systems biophysics
- URL: https://journals.rcsi.science/0006-3029/article/view/264949
- DOI: https://doi.org/10.31857/S0006302924040168
- EDN: https://elibrary.ru/NFWNTA
- ID: 264949
Cite item
Abstract
About the authors
N. V Belosludtseva
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences
Email: belosludtsevanv@iteb.pushchino.ru
Pushchino, Russia
T. A Uryupina
Institute of Theoretical and Experimental Biophysics, Russian Academy of SciencesPushchino, Russia
D. A Khurtin
Mari State UniversityYoshkar-Ola, Russia
N. V Khunderyakova
Institute of Theoretical and Experimental Biophysics, Russian Academy of SciencesPushchino, Russia
G. D Mironova
Institute of Theoretical and Experimental Biophysics, Russian Academy of SciencesPushchino, Russia
References
- Lindstrom M., DeCleene N., Dorsey H., Fuster V., Johnson C. O., LeGrand K. E., Mensah G. A., Razo C., Stark B., Varieur Turco J., and Roth G. A. Global burden of cardiovascular diseases and risks collaboration. J. Am. Coll. Cardiol., 80 (25), 2372–2425 (2022). doi: 10.1016/j.jacc.2022.11.001
- Marzilli M., Merz C. N., Boden W. E., Bonow R. O., Capozza P. G., Chilian W. M., DeMaria A. N., Guarini G., Huqi A., Morrone D., Patel M. R., and Weintraub W. S. Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! J. Am. Coll. Cardiol., 60 (11), 951–956 (2012). doi: 10.1016/j.jacc.2012.02.082
- Ponikowski P., Voors A. A., Anker S. D., Bueno H., Cleland J. G. F., Coats A. J. S., Falk V., Gonzalez-Juanatey J. R., Harjola V.-P., Jankowska E. A., Jessup M., Linde C., Nihoyannopoulos P., Parissis J. T., Pieske B., Riley J. P., Rosano G. M. C., Ruilope L. M., Ruschitzka F., Rutten F. H., and van der Meer P. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J., 37 (27), 2129–2200 (2016). doi: 10.1093/eurheartj/ehw128
- Severino P., D'Amato A., Pucci M., Infusino F., Birtolo L. I., Mariani M. V., Lavalle C., Maestrini V., Mancone M., and Fedele F. Ischemic heart disease and heart failure: role of coronary ion channels. Int. J. Mol. Sci., 21 (9), 3167 (2020). doi: 10.3390/ijms21093167
- Marzilli M. Myocardial energy balance and metabolism as causes of myocardial ischemia. Vascul. Pharmacol., 154, 107273 (2024). doi: 10.1016/j.vph.2023.107273
- Pepine C. J. and Douglas P. S. Rethinking stable ischemic heart disease: is this the beginning of a new era? J. Am. Coll. Cardiol., 60, 11, 957–959 (2012). doi: 10.1016/j.jacc.2012.04.046
- Tamis-Holland J. E., Jneid H., Reynolds H. R., Agewall S., Brilakis E. S., Brown T. M., Lerman A., Cushman M., Kumbhani Dh. J., Arslanian-Engoren C., Bolger A. F., and Beltrame J. F. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: A scientific statement from the american heart association. Circulation, 139 (18), 891–908 (2019). doi: 10.1161/CIR.0000000000000670
- Kuznetsov A. V., Javadov S., Margreiter R., Grimm M., Hagenbuchner J., and Ausserlechner M. J. The role of mitochondria in the mechanisms of cardiac ischemia-reperfusion injury. Antioxidants (Basel), 8 (10), 454 (2019). doi: 10.3390/antiox8100454
- Ramaraj R. Stress cardiomyopathy: aetiology and management. Postgrad. Med. J., 83 (982), 543–546 (2007). doi: 10.1136/pgmj.2007.058776
- Yoganathan T., Perez-Liva M., Balvay D., Le Gall M., Lallemand A., Certain A., Autret G., Mokrani Ya., Guillonneau F., Bruce J., Nguyen V., Gencer U., Schmitt A., Lager F., Guilbert Th., Bruneval P., Vilar J., Maissa N., Mousseaux E., Viel Th., Renault G., Kachenoura N., and B. Tavitian Acute stress induces long-term metabolic, functional, and structural remodeling of the heart. Nat. Commun., 14 (1), 3835 (2023). doi: 10.1038/s41467-023-39910-7
- Boarescu P.-M., Boarescu I., Bulboaca A., Parvu A., Gheban D., and Bolboaca S. Isoproterenol induced myocardial infarction in rats: dose identification. Clujul. Med., 91, S39–S40 (2018). doi: 10.1016/j.phyplu.2023.100472
- Diao H., Gu H., and Chen Q. M. Hyperkalemic or low potassium cardioplegia protects against reduction of energy metabolism by oxidative stress. Antioxidants (Basel), 2023 12 (2), 452 (2023). doi: 10.3390/antiox12020452
- Guarini G., Huqi A., Morrone D., and Marzilli M. Pharmacological agents targeting myocardial metabolism for the management of chronic stable angina : an update. Cardiovasc. Drugs Ther., 30 (4), 379–391 (2016). doi: 10.1007/s10557-016-6677-y
- Horton J. L. and Virag J. Use of multifactorial treatments to address the challenge of translating experimental myocardial infarct reduction strategies. Int. J. Mol. Sci., 20 (6), 1449 (2019). doi: 10.3390/ijms20061449
- Mironova G. D., Negoda A. E., Marinov B. S., Paucek P., Costa A. D., Grigoriev S. M., Skarga Y. Y., and Garlid K. D. Functional distinctions between the mitochondrial ATP-dependent K+ channel (mitoKATP) and its inward rectifier subunit (mitoKIR). J. Biol. Chem., 279 (31), 32562–32568 (2004). doi: 10.1074/jbc.M401115200
- Zhang Y., Guo S., Xie C., and Fang J. Uridine Metabolism and its role in glucose, lipid, and amino acid homeostasis. Biomed. Res. Int., 7091718 (2020). doi: 10.1155/2020/7091718
- Mironova G. D., Khrenov M. O., Talanov E. Y., Glushkova O. V., Parfenyuk S. B., Novoselova T. V., Lunin S. M., Belosludtseva N. V., Novoselova E. G., and Lemasters J. J. The role of mitochondrial KATP channel in anti-inflammatory effects of uridine in endotoxemic mice. Arch. Biochem. Biophys., 654, 70–76 (2018). doi: 10.1016/j.abb.2018.07.006
- Krylova I. B., Selina E. N., Bulion V. V., Rodionova O. M., Evdokimova N. R., Belosludtseva N. V., Shigaeva M. I., and Mironova G. D. Uridine treatment prevents myocardial injury in rat models of acute ischemia and ischemia/reperfusion by activating the mitochondrial ATPdependent potassium channel. Sci. Rep., 11 (1), 16999 (2019). doi: 10.1038/s41598-021-96562-7
- Belosludtseva N. V., Starinets V. S., Mikheeva I. B., Belosludtsev M. N., Dubinin M. V., Mironova G. D., and Belosludtsev K. N. Effect of chronic treatment with uridine on cardiac mitochondrial dysfunction in the C57BL/6 mouse model of high-fat diet-streptozotocininduced diabetes. Int. J. Mol. Sci., 23 (18), 10633 (2022). doi: 10.3390/ijms231810633
- Liu Z., Li W., Geng L., Sun L., Wang Q., Yu Y., Yan P., Liang Ch., Ren J., Song M., Zhao Q., Lei J., Cai Yu., Li J., Yan K., Wu Z., Chu Q., Li J., Wang S., Li Ch., Han J.-D. J., Hernandez-Benitez R., ShyhChang Ng., Belmonte J. C. I., Zhang W., Qu J., and Liu G.-H., Cross-species metabolomic analysis identifies uridine as a potent regeneration promoting actor. Cell Discov., 8 (1), 6 (2022). doi: 10.1038/s41421-021-00361-3
- Yamamoto T., Koyama H., Kurajoh M., Shoji T., Tsutsumi Z., and Moriwaki Y. Biochemistry of uridine in plasma. Clin. Chim. Acta, 412 (19–20), 1712–1724 (2011). doi: 10.1016/j.cca.2011.06.006
- Krylova I. B., Kachaeva E. V., Rodionova O. M., Negoda A. E., Evdokimova N. R., Balina M. I., Sapronov N. S., and Mironova G. D. The cardioprotective effect of uridine and uridine-5'-monophosphate: the role of the mitochondrial ATP-dependent potassium channel. Exp. Gerontol., 41 (7), 697–703 (2006). doi: 10.1016/j.exger.2006.03.005
- Khunderyakova N. V., Yachkula T. V., Zakharchenko M. V., Plyasunova S. A., Sukhorukov V. S., Baranich, N. I., Litvinova E. G., Fedotcheva N., Schwartsburd P., and Kondrashova M., Cytobiochemical biomarkers of the state of mitochondria in Humans. I. A new assessment of Warburg effect by the ratio of lactate dehydrogenase to succinate dehydrogenase activity in lymphocytes as a distinct biomarker of pronounced differences between leukemia, norm and myopathy in young patients. J. World Mitochondria Soc., 2 (2) (2017). doi: 10.18143/JWMS_v2i2_1930
- Nichtova Z., Novotova M., Kralova E., and Stankovicova T. Morphological and functional characteristics of models of experimental myocardial injury induced by isoproterenol. Gen. Physiol. Biophys., 31 (2), 141–151 (2012). doi: 10.4149/gpb_2012_015
- Krestinin R., Baburina Y., Odinokova I., Kruglov A., Sotnikova L., and Krestinina O. The Effect of Astaxanthin on Mitochondrial Dynamics in Rat Heart Mitochondria under ISO-Induced Injury. Antioxidants (Basel), 12 (6), 1247 (2023). doi: 10.3390/antiox12061247
- Belosludtseva N. V., Pavlik L. L., Mikheeva I. B., Talanov E. Y., Serov D. A., Khurtin D. A., Belosludtsev K.N., and Mironova G. D. Protective Effect of Uridine on Structural and Functional Rearrangements in Heart Mitochondria after a High-Dose Isoprenaline Exposure Modelling Stress-Induced Cardiomyopathy in Rats. Int . J. Mol. Sci., 24 (24), 17300 (2023). doi: 10.3390/ijms242417300
- Feng W. and Li W. The study of ISO induced heart failure rat model. Exp. Mol. Pathol., 88 (2), 299–304 (2010). doi: 10.1016/j.yexmp.2009.10.011
- Pham V. A., Tran H. Th., Mai Th. Ph., Nguyen L. H., Nguyen V. H., Nguyen Th. H., Bui S. S., Vu A. V., Do H. Th., Trinh Q. V. Myocardial infarction model induced by isoproterenol in rats and potential cardiovascular protective effect of a nattokinase-containing hard capsule. Phytomed. Plus, 3, 100472, 2667–0313 (2023). doi: 10.1016/j.phyplu.2023.100472
- Xu X., Zhang X., Cheng S., Li Q., Chen C., and Ouyang M. Protective effect of uridine on atrial fibrillation: a Mendelian randomisation study. Sci. Rep., 13 (1), 19639 (2023). doi: 10.1038/s41598-023-47025-8
- Cheng T., Wang H., and Hu Y. The causal effects of genetically determined human blood metabolites on the risk of atrial fibrillation. Front. Cardiovasc. Med., 10, 1211458 (2023). doi: 10.3389/fcvm.2023.1211458